Completed study

Official Study Title
A randomized prospective clinical trial to assess the role of PROcalcitonin-Guided antimicrobial therapy to REduce long-term infectionS Sequelae

Brief Description
PROGRESS is a randomized clinical trial aiming to test the efficacy of an algorithm of the duration of antimicrobial treatment based on serum procalcitonin in patients with sepsis on the development of resistant bowel microbiota and of infections by Clostridium difficile.

Status: Completed
Study Type: Interventional (Clinical Trial)
Study phase: II
Study sites: 7 sites in Greece
Actual enrolment: 266 participants Identifier: NCT03333304
EudraCT number: 2017-002011-33
National Organization for Medicines Approval: IS 62-17
National Ethics Committee Approval: 62/17

Study Start: October 2017
Study Completion: July 2019

Condition/Disease studied: Sepsis
Keywords: Procalcitonin

Related publications